Financing, Equity Capital Markets

OncoCyte Corporation

02/21
|
$40.6 Million
Piper Sandler served as left bookrunner for OncoCyte Corporation on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Tools & Diagnostics